AC
HCAT icon

AXQ Capital’s Health Catalyst HCAT Stock Holding History

AXQ Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,059
Closed -$51.5K – 814
2025
Q3 		$51.5K Buy
+18,059
New +$61.8K 0.02% 543
2024
Q1 		– Sell
-17,823
Closed -$165K – 734
2023
Q4 		$165K Buy
+17,823
New +$146K 0.04% 561

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AXQ Capital's HCAT Position: Q4 2025 in Review

AXQ Capital sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 18,059 shares — an estimated $51.5K sold.

AXQ Capital first reported a position in HCAT in Q4 2023 and held it in 2 quarters. The position peaked at $165K in Q4 2023. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • AXQ Capital reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • AXQ Capital sold 18,059 Health Catalyst shares in Q4 2025, an estimated $51.5K.
  • AXQ Capital first reported a position in Health Catalyst in Q4 2023 and held it in 2 quarters.
  • AXQ Capital's Health Catalyst position peaked at $165K in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on AXQ Capital's 13F filing for Q4 2025, filed 10 Feb 2026.